Pediatrix Medical Group, Inc.

MDNYSEHealthcare● Active

$22.61

+$0.24(+1.07%)

Market Cap$1.9B

P/E Ratio—

52W High$24.99

52W Low$11.84

Avg Volume841K

Open$22.52

Beta0.70

Free Cash Flow Financials Revenue

Pediatrix Medical Group, Inc. (MD) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

MD · free cash flow · updated Jun 8, 2026

Core FCF metrics

MD · FCF · TTM · margin & CAGR

Free cash flow was $252.6M for FY2025 (fiscal year ending 2025-12-31), up 36.9% year-over-year The FCF margin was 13.2%. Five-year CAGR stands at +7.5%.

FY2025 Free Cash Flow$252.6M▲ +36.9% YoY

Trailing 12M (TTM)$237.7Mtrailing 4 quarters sum

FCF Margin13.2%$252.6M ÷ revenue

3-Year CAGR+22.6%FY2022 → FY2025

5-Year CAGR+7.5%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

MD · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$271.1M(18M)$252.6M▲ +36.9%13.2%

FY2024$206.6M(22M)$184.6M▲ +77.5%9.2%

FY2023$137.3M(33M)$104.0M▼ 24.2%5.2%

FY2022$166.9M(30M)$137.2M▲ +208.5%7.0%

FY2021$76.7M(32M)$44.5M▼ 74.7%2.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

MD · P/FCF · FCF yield · FCF per share

Pediatrix Medical Group, Inc. (MD) trades at a FCF yield of 12.80% and a price-to-free-cash-flow ratio of 8.1x. FCF per share stands at $2.79, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

12.80%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$2.79

TTM FCF ÷ Shares Outstanding

Price / FCF

x8.1

Share Price ÷ FCF per Share

EV / FCF (TTM)

x9.6

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

MD · cash flow statement · operating / investing / financing

For FY2025, Pediatrix Medical Group, Inc. generated $271.1M in operating cash flow and spent 18M in capital expenditures, yielding $252.6M in free cash flow.

Operating Activities

+$271.1M

Cash from core business operations

2025-12-31

Investing Activities

−$18.3M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$107.5M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($271.1M) − |CapEx| (18M) = FCF ($252.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

MD vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Pediatrix Medical Group, Inc.YOU

$252.6M+36.9%13.2%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Pediatrix Medical Group, Inc. (MD) reported free cash flow of $252.6M for FY2025 (fiscal year ending 2025-12-31), up 36.9% year-over-year. The FCF margin was 13.2%.

Based on available data, Pediatrix Medical Group, Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $462.1M in FY2017. The 5-year CAGR stands at +7.5%.

Pediatrix Medical Group, Inc.'s FCF yield is 12.80% and price-to-FCF ratio is 8.1x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

MD free cash flow · 8 questions

Pediatrix Medical Group, Inc. free cash flow was $252.6M for FY2025, up 36.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $237.7M.

MD free cash flowMD FCFMD FCF 2025MD free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Pediatrix Medical Group, Inc. · Pediatrix Medical Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026